JY
SANA icon

Jeff Yass’s Sana Biotechnology SANA Stock Holding History

Jeff Yass’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$695K Buy
199,000
+8,600
+5% +$27.7K ﹤0.01% 9121
2026
Q1 		$548K Buy
190,400
+48,900
+35% +$193K ﹤0.01% 9421
2025
Q4 		$576K Buy
141,500
+101,800
+256% +$456K ﹤0.01% 8456
2025
Q3 		$141K Sell
39,700
-128,000
-76% -$463K ﹤0.01% 11328
2025
Q2 		$458K Buy
167,700
+63,500
+61% +$131K ﹤0.01% 9377
2025
Q1 		$175K Sell
104,200
-174,700
-63% -$488K ﹤0.01% 11081
2024
Q4 		$455K Sell
278,900
-64,100
-19% -$191K ﹤0.01% 8915
2024
Q3 		$1.43M Buy
343,000
+117,400
+52% +$617K ﹤0.01% 6020
2024
Q2 		$1.23M Buy
225,600
+7,600
+3% +$60.6K ﹤0.01% 6089
2024
Q1 		$2.18M Buy
218,000
+194,500
+828% +$1.46M ﹤0.01% 5128
2023
Q4 		$95.9K Buy
23,500
+8,100
+53% +$29.8K ﹤0.01% 11364
2023
Q3 		$59.6K Sell
15,400
-392,800
-96% -$2.11M ﹤0.01% 11215
2023
Q2 		$2.43M Buy
+408,200
New +$2.35M ﹤0.01% 4747
2022
Q3 		– Sell
-10,300
Closed -$66K – 13997
2022
Q2 		$66K Sell
10,300
-6,200
-38% -$39.5K ﹤0.01% 11809
2022
Q1 		$136K Buy
16,500
+5,200
+46% +$42K ﹤0.01% 11646
2021
Q4 		$175K Buy
+11,300
New +$218K ﹤0.01% 11604

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Jeff Yass's SANA Position: Q2 2026 in Review

Jeff Yass reduced its Sana Biotechnology (SANA) stake by 8.9% in Q2 2026, selling an estimated $121K and leaving 384,083 shares worth $1.34M. The position accounts for ﹤0.01% of the portfolio, ranked #7450.

Jeff Yass first reported a position in SANA in Q2 2021 and has held it in 21 quarters since. The position peaked at $2.28M in Q4 2025. 208 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • Jeff Yass held 384,083 shares of Sana Biotechnology worth $1.34M as of Q2 2026.
  • Jeff Yass sold 37,472 Sana Biotechnology shares in Q2 2026, an estimated $121K.
  • Sana Biotechnology made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #7450 holding.
  • Jeff Yass first reported a position in Sana Biotechnology in Q2 2021 and has held it in 21 quarters since.
  • Jeff Yass's Sana Biotechnology position peaked at $2.28M in Q4 2025.
  • 208 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.